| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |